Kombiglyze Xr
Type 2 Diabetes Mellitus
5/500 · 5/1000mg
Utilized to manage type 2 diabetes to support glycaemic control.
Saxagliptin functions as a DPP-4 inhibitor to manage blood glucose levels in adults, typically alongside diet and exercise. Our catalogue lists Kombiglyze Xr, featuring the active ingredient saxagliptin in a prolonged-release format. This medication belongs to a class central to effective Diabetes Management.
Type 2 Diabetes Mellitus
5/500 · 5/1000mg
Utilized to manage type 2 diabetes to support glycaemic control.
Saxagliptin is a medication classified as a DPP-4 inhibitor, which regulates glucose levels by increasing natural hormones in your body. It is formulated to complement your existing dietary and exercise routines. Because medication responses vary, you may find that specific releases provide more consistency for your personal daily routine.
This compound is used primarily for the long-term management of Type 2 Diabetes. By working to keep post-meal blood sugar levels within a target range, the medication supports your body in processing glucose more effectively. It is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis.
This ingredient works by blocking the enzyme that breaks down incretin hormones. These hormones increase the amount of insulin produced when your blood sugar is high and lower the amount of sugar produced by your liver. This combined process maintains balanced glucose levels throughout the day.
The primary formulation listed is the prolonged-release tablet of Kombiglyze. Prolonged-release technology is designed to distribute the active ingredient gradually over a longer period, which can simplify your daily routine by reducing the number of times you need to take the medication. When choosing a product, consider the release mechanism and your preference for how you take the tablet.
When you require a specific formulation, browsing through available brands allows you to compare products and options. We provide access to Kombiglyze Xr for delivery across Malaysia and Thailand, as well as shipments to other markets such as the Philippines, Indonesia and Hong Kong. You can select the specific product that meets your needs for ongoing care through our secure ordering platform.
Verify that this medication aligns with your current health profile, including your kidney and liver status. You should confirm the active ingredients to avoid sensitivities or duplication of similar DPP-4 inhibitor treatments.
Common responses can include mild respiratory symptoms, urinary tract issues, or digestive discomfort. Monitor your glucose levels regularly to observe how your body reacts to the introduction of this medication.
Certain medications, especially those affecting glucose metabolism or insulin secretion, may interact with this compound. Product labelling and verified clinical sources remain the correct references for specific contraindications, interactions and reactions.
This is an educational overview, not medical advice. Saxagliptin products differ in their specific release mechanism, dosage, and directions. This page does not authorise clinical application or unsupervised use of any listed medication. You must review the individual product labelling provided with your order and speak with a healthcare professional when clinical or diagnostic judgement is required regarding your personal treatment plan.